Livzon Pharmaceutical Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	278,407 shares
P/E Ratio:	13.24
Forward P/E:	13.29
EPS:	2.66 HKD
Forward EPS:	2.65 HKD
Number of Shares:	299,807,117 shares
Market Capitalization:	35,780,116,480.00 HKD

The interactive chart displays the price movement of Livzon Pharmaceutical shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company Livzon Pharmaceutical pays a dividend of 1.2 HKD per share. The annual dividend yield is 3.46%. The average dividend yield over the last 5 years is 5.53%. The payout ratio is 102.97%. The last paid dividend was 1.198758 HKD, paid on 2025-06-13. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2025-06-13.

Dividend	Value
Dividend Amount	The company Livzon Pharmaceutical pays a dividend of 1.2 HKD per share.
Annual Yield %:	3.46 %
Ex-dividend Date:	2025-06-13
5-Year Avg Yield %:	5.53 %
Payout Ratio:	102.97 %
Last Dividend Value:	1.198758 HKD
Last Dividend Date:	2025-06-13

Analyst Forecast

Most analysts have issued a buy recommendation for Livzon Pharmaceutical stock. The current number of analysts covering this company is 5. The highest target price is 48.1236 HKD, while the lowest target price is 26.129736 HKD. The median target valuation set by analysts is 37.217365 HKD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Livzon Pharmaceutical.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Livzon Pharmaceutical stock is: buy
Number of Analysts:	5
Highest Target Price:	48.1236 HKD
Lowest Target Price:	26.129736 HKD
Median Target Price:	37.217365 HKD

Fundamental Indicators

Indicator	Data
Total Revenue:	11,801,896,960.00 HKD
Net Income:	2,171,212,800.00 HKD
Price-to-Book (P/B):	2.30
PEG Ratio:	/
Exchange:	HKSE
Industry:	Drug Manufacturers - Specialty & Generic
Sector:	Healthcare
Number of Employees:	9067
Country:	China

Where to Buy Livzon Pharmaceutical Stock?

You can purchase Livzon Pharmaceutical stock on the HKSE under the ticker symbol: 1513.HK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Livzon Pharmaceutical Stock

Indicator	Value
Company Revenue:	11,801,896,960.00 HKD
EBITDA:	3,190,264,576.00 HKD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	2.66 HKD
Book Value Per Share:	15.32 HKD
Total Cash:	10,824,910,848.00 HKD
Total Cash per Share:	12.13 HKD
Total Debt:	3,619,549,952.00 HKD
Debt to Equity Ratio:	0.24
Quick Ratio	1.93
Current Ratio	2.19
Free Cash Flow	906,873,600.00 HKD
Operating Cash Flow	3,135,757,056.00 HKD
Gross Margins	64.21 %
EBITDA Margins	27.03 %
Operating Margins	23.66 %
Profit Margins	18.40 %
Return on Assets	6.6 %
Return on Equity	16.9 %
Earnings Growth (1 year)	16.3%
Revenue Growth (1 year)	1.7 %
Quarterly Earnings Year-over-Year Growth	14.4 %
Market Capitalization	35,780,116,480.00 HKD
Enterprise Value	25,484,890,112.00 HKD
EV/Revenue	2.159
EV/EBITDA	7.988
Float Shares	463,255,431 shares
Shares Outstanding	299,807,117 shares
Held Percent Insiders	0.54 %
Held Percent Institutions	12.11 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.23
Short Percentage of Float	-
Implied Shares Outstanding	1,015,903,289

Frequently Asked Questions (FAQ)

1️⃣ Does Livzon Pharmaceutical pay dividends?

The company Livzon Pharmaceutical pays a dividend of 1.2 HKD per share. At this rate, the annual yield is 3.46 %.

2️⃣ Where to buy Livzon Pharmaceutical shares?

Livzon Pharmaceutical shares are traded on the HKSE stock exchange under the ticker: 1513.HK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Livzon Pharmaceutical shares?

According to our data, the recommendation for Livzon Pharmaceutical shares is from a total of 5 analysts. The average target price prediction is 37.217365 HKD per share.

4️⃣ What is the total number of shares and the value of Livzon Pharmaceutical on the stock exchange?

The total number of Livzon Pharmaceutical shares on the exchange is 299,807,117.00 shares, which at the current market capitalization gives the company a total valuation of 35,780,116,480.00 HKD.